BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 29056165)

  • 1. The Leaky Gut and Altered Microbiome in Chronic Kidney Disease.
    Lau WL; Vaziri ND
    J Ren Nutr; 2017 Nov; 27(6):458-461. PubMed ID: 29056165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Uremic toxins and gut micro biome].
    Vaziri ND; Suematsu Y; Shimomura A; Vaziri ND
    Nihon Jinzo Gakkai Shi; 2017; 59(4):535-544. PubMed ID: 30620802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of CKD on Uremic Toxins and Gut Microbiota.
    Rysz J; Franczyk B; Ławiński J; Olszewski R; Ciałkowska-Rysz A; Gluba-Brzózka A
    Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33807343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiome in chronic kidney disease: challenges and opportunities.
    Nallu A; Sharma S; Ramezani A; Muralidharan J; Raj D
    Transl Res; 2017 Jan; 179():24-37. PubMed ID: 27187743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic kidney disease and the gut microbiome.
    Hobby GP; Karaduta O; Dusio GF; Singh M; Zybailov BL; Arthur JM
    Am J Physiol Renal Physiol; 2019 Jun; 316(6):F1211-F1217. PubMed ID: 30864840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the gastrointestinal tract and microbiota on uremic toxins and chronic kidney disease development.
    Briskey D; Tucker P; Johnson DW; Coombes JS
    Clin Exp Nephrol; 2017 Feb; 21(1):7-15. PubMed ID: 26965149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered intestinal microbial flora and impaired epithelial barrier structure and function in CKD: the nature, mechanisms, consequences and potential treatment.
    Vaziri ND; Zhao YY; Pahl MV
    Nephrol Dial Transplant; 2016 May; 31(5):737-46. PubMed ID: 25883197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CKD impairs barrier function and alters microbial flora of the intestine: a major link to inflammation and uremic toxicity.
    Vaziri ND
    Curr Opin Nephrol Hypertens; 2012 Nov; 21(6):587-92. PubMed ID: 23010760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathomechanism and treatment of gut microbiota dysbiosis in chronic kidney disease and interventional effects of Chinese herbal medicine].
    Han WB; Liu YL; Wan YG; Sun W; Tu Y; Yang JJ; Wu W; He WM; Yao J
    Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(13):2425-2432. PubMed ID: 28840678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiota in chronic kidney disease.
    Cigarran Guldris S; González Parra E; Cases Amenós A
    Nefrologia; 2017; 37(1):9-19. PubMed ID: 27553986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Micro-inflammation and digestive bacterial translocation in chronic kidney disease].
    Olivier V; Dunyach-Remy C; Lavigne JP; Moranne O
    Nephrol Ther; 2018 May; 14(3):135-141. PubMed ID: 29295767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut-Derived Protein-Bound Uremic Toxins.
    Graboski AL; Redinbo MR
    Toxins (Basel); 2020 Sep; 12(9):. PubMed ID: 32932981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbiota issue in CKD: how promising are gut-targeted approaches?
    Cosola C; Rocchetti MT; Sabatino A; Fiaccadori E; Di Iorio BR; Gesualdo L
    J Nephrol; 2019 Feb; 32(1):27-37. PubMed ID: 30069677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombolome and Its Emerging Role in Chronic Kidney Diseases.
    Fryc J; Naumnik B
    Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33803899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The crosstalk of gut microbiota and chronic kidney disease: role of inflammation, proteinuria, hypertension, and diabetes mellitus.
    Kanbay M; Onal EM; Afsar B; Dagel T; Yerlikaya A; Covic A; Vaziri ND
    Int Urol Nephrol; 2018 Aug; 50(8):1453-1466. PubMed ID: 29728993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The gut-kidney axis.
    Evenepoel P; Poesen R; Meijers B
    Pediatr Nephrol; 2017 Nov; 32(11):2005-2014. PubMed ID: 27848096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut Microbiome in Chronic Kidney Disease.
    Armani RG; Ramezani A; Yasir A; Sharama S; Canziani MEF; Raj DS
    Curr Hypertens Rep; 2017 Apr; 19(4):29. PubMed ID: 28343357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contributory Role of Gut Microbiota and Their Metabolites Toward Cardiovascular Complications in Chronic Kidney Disease.
    Li DY; Tang WHW
    Semin Nephrol; 2018 Mar; 38(2):193-205. PubMed ID: 29602401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal Dysbiosis, Barrier Dysfunction, and Bacterial Translocation Account for CKD-Related Systemic Inflammation.
    Andersen K; Kesper MS; Marschner JA; Konrad L; Ryu M; Kumar Vr S; Kulkarni OP; Mulay SR; Romoli S; Demleitner J; Schiller P; Dietrich A; Müller S; Gross O; Ruscheweyh HJ; Huson DH; Stecher B; Anders HJ
    J Am Soc Nephrol; 2017 Jan; 28(1):76-83. PubMed ID: 27151924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut-Derived Metabolites and Their Role in Immune Dysfunction in Chronic Kidney Disease.
    Glorieux G; Gryp T; Perna A
    Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32290429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.